Clinical Trial: Exploratory Study Evaluating the Effects of Dermo-cosmetic RV5026B Applied for 2 Months in Adults with Erythrocouperosis

U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT06824870) titled 'Exploratory Study Evaluating the Effects of Dermo-cosmetic RV5026B Applied for 2 Months in Adults with Erythrocouperosis' on Feb. 07.

Brief Summary: This exploratory study aims to evaluate the effects of the test product RV5026B - ET1732 on erythema, as well as on the sensations of discomfort and relief perceived in subjects with erythrocouperose and associated pityriasis folliculorum.

We wish to evaluate:

* firstly the test product alone in order to quantify the effects on the signs & symptoms on the entire face,

* then the contribution of the test product in addition to a reference topical treatment.

The test product RV5026B -...